$CELG Recent News Some of the Nasdaq’s leading lights

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$CELG Recent News

Some of the Nasdaq’s leading lights have begun to dim 2:02 p.m. Jan. 15, 2015 - The Trading Deck
GameStop shares rally on strong holiday sales 5:48 p.m. Jan. 13, 2015 - MarketWatch
Celgene shares gain 3.6% to top S&P 500 9:40 a.m. Jan. 13, 2015 - Sue Chang
Three investments to own and three to 6:00 a.m. Jan. 13, 2015 - Howard Gold
Updates, advisories and surprises 12:31 p.m. Jan. 12, 2015 - MarketWatch
Celgene's 2015 profit outlook is below forecasts 12:18 p.m. Jan. 12, 2015 - MarketWatch.com
Celgene's stock rises, but off highs after profit outlook 11:48 a.m. Jan. 12, 2015 - Tomi Kilgore
Celgene's stock gains 1.2% after Q4 profit view tops expectations 11:26 a.m. Jan. 12, 2015 - Tomi Kilgore
Why speculators see opportunity in younger, cyclical stocks 2:50 p.m. Dec. 26, 2014 - The Trading Deck
GoPro, Gilead Sciences, Celgene gain 11:27 a.m. Dec. 26, 2014 - MarketWatch
Dow ekes out gain for 37th record close of 2014 2:55 p.m. Dec. 24, 2014 - Carla Mozee
GoPro, Adamas climb, Cal-Maine slides 10:06 a.m. Dec. 24, 2014 - MarketWatch
Cal-Maine Foods shares fall on earnings miss 4:41 p.m. Dec. 23, 2014 - Barbara Kollmeyer
A teachable moment: Here are my worst stock picks of 2014 10:19 a.m. Dec. 23, 2014 - Jeff Reeves
Four signs that would indicate a new uptrend 2:52 p.m. Dec. 16, 2014 - The Trading Deck
Liquid growth stocks tell interesting tale 3:10 p.m. Dec. 9, 2014 - The Trading Deck
H&R Block shares fall on quarterly miss 6:41 p.m. Dec. 8, 2014 - Sue Chang
The S&P 500 recorded its biggest drop in nearly 7 weeks 4:33 p.m. Dec. 8, 2014 - Sara Sjolin
Celgene shares climb 1.9% 9:30 a.m. Dec. 8, 2014 - Sue Chang
Is the next Cisco out there? 3:23 p.m. Nov. 25, 2014 - The Trading Deck


Otezla cleared in Europe 9:36 a.m. Today - Seeking Alpha
Zacks Rank #1 Additions for Thursday - Tale of the Tape 9:30 a.m. Jan. 15, 2015 - Zacks.com
Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics Give Strong Outlook - Analyst Blog 2:39 p.m. Jan. 14, 2015 - Zacks.com
Celgene Sells Off, But Begins Move Back Up 9:48 a.m. Jan. 14, 2015 - benzinga.com
Express Scripts is Biotech's Grinch 9:13 a.m. Jan. 14, 2015 - Seeking Alpha
Meet 5 Top Medical Stocks Making Waves This Week 7:02 a.m. Jan. 14, 2015 - Investors Business Daily
Jim Cramer's Top Stock Picks: AAPL FLEX DIS CELG HALO 6:00 a.m. Jan. 14, 2015 - TheStreet.com
Cramer's Mad Money: A Different Kind Of Market (1/13/15) 12:37 a.m. Jan. 14, 2015 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: How to Maneuver in a Trader's Market 8:20 p.m. Jan. 13, 2015 - TheStreet.com
Celgene's Preliminary Results & 2015 Outlook Encouraging - Analyst Blog 7:20 p.m. Jan. 13, 2015 - Zacks.com
Celgene CEO Explains The Reasons Behind Company's Ambitious Guidance 8:06 a.m. Jan. 13, 2015 - benzinga.com
Short Interest in Biotechs Signals Optimism 7:58 a.m. Jan. 13, 2015 - 247WallSt.com
Jim Cramer's Top Stock Picks: ISIS CELG NPSP AA ACOR 6:00 a.m. Jan. 13, 2015 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Blame Tech, Oil and Retail for Today's Losses 8:32 p.m. Jan. 12, 2015 - TheStreet.com
Celgene, Bristol-Myers Cancer Drug News Lifts Stocks 5:48 p.m. Jan. 12, 2015 - Investors Business Daily
Watch For Today's Momo Momentum Stock: Celgene (CELG) 1:51 p.m. Jan. 12, 2015 - TheStreet.com
Celgene Says Q4 Earnings Beat, Sees Currency Impact 12:52 p.m. Jan. 12, 2015 - Investors Business Daily
Digging Deeper: Outperforming Stocks In The Leading Health Care Sector 12:10 p.m. Jan. 12, 2015 - Seeking Alpha
Celgene Expects to More Than Triple Earnings by 2020 11:25 a.m. Jan. 12, 2015 - 247WallSt.com
5 Biotech Stocks With Explosive Drug Pipelines 8:01 a.m. Jan. 12, 2015 - InvestorPlace.com


Oral OTEZLA® (apremilast) Approved by the European Commission for the Treatment of both Patients with Psoriasis and Psoriatic Arthritis 9:10 a.m. Today - BusinessWire - BZX
Hogging the Limelight: New Research on Netlist, Celgene, Jamba, Citigroup and Tilly's 8:40 a.m. Jan. 14, 2015 - PR Newswire - PRF
Biotechs to Follow in 2015 off Fresh Insider Moves 10:00 a.m. Jan. 6, 2015 - ACCESSWIRE
Celgene Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference 8:31 a.m. Jan. 6, 2015 - BusinessWire - BZX
Critical Alerts For Invensense, FireEye, General Electric, Twitter and Celgene Released By InvestorsObserver 9:31 a.m. Dec. 22, 2014 - PR Newswire - PRF
Scanning Biotech Equities -- Celgene, Novavax, Amarin, Immunomedics, and Aeterna Zentaris 8:40 a.m. Dec. 17, 2014 - PR Newswire - PRF
Data Presented on REVLIMID® (lenalidomide) Compared with Investigators’ Choice in Relapsed/Refractory Diffuse Large B-Cell Lymphoma 8:34 p.m. Dec. 8, 2014 - BusinessWire - BZX
Additional Analyses of High-Risk Patients from Phase III Study (AML-001) OF Vidaza® (Azacitidine for Injection) in Acute Myeloid Leukemia Presented at ASH 8:33 p.m. Dec. 8, 2014 - BusinessWire - BZX
REVLIMID® (Lenalidomide) Single-Agent and Combination Studies in Mantle Cell Lymphoma (MCL) Presented at ASH 8:33 p.m. Dec. 8, 2014 - BusinessWire - BZX
New Data in Myelodysplastic Syndromes Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition 2:00 p.m. Dec. 8, 2014 - BusinessWire - BZX
Results from Phase III Study of REVLIMID® (Lenalidomide) Demonstrating Improved Transfusion Independence in Patients with Rare Blood Cancer, Non-Del-5Q Myelodysplastic Syndromes (MDS), Presented at ASH 1:49 p.m. Dec. 8, 2014 - BusinessWire - BZX
Age, Renal Impairment and Depth of Response Analyses of the FirstTM (MM-020/IFM 07-01)Study of Continuous REVLIMID® (lenalidomide) Plus Low-Dose dexamethasone in Newly-Diagnosed Multiple Myeloma Presented at ASH 9:58 p.m. Dec. 7, 2014 - BusinessWire - BZX
Critical Alerts For Noodles & Company, Goldcorp, YY, Celgene and LinkedIn Released By InvestorsObserver 9:31 a.m. Dec. 2, 2014 - PR Newswire - PRF
Celgene Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Corporation 4:30 p.m. Dec. 1, 2014 - BusinessWire - BZX
Celgene Receives Positive CHMP Opinion for OTEZLA® (apremilast), the First Oral PDE4 Inhibitor for the Treatment of Patients with Psoriasis and Psoriatic Arthritis 6:00 a.m. Nov. 21, 2014 - BusinessWire - BZX
Chef Michael Ferraro, the Pancreatic Cancer Action Network and Meals to Heal Team up with Celgene to Address Nutritional Needs and Challenges Faced by Pancreatic Cancer Patients and Caregivers 8:00 a.m. Nov. 20, 2014 - BusinessWire - BZX
UPDATE: Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Well Tolerated and Increases CD4 Counts in People Living With HIV 4:29 p.m. Nov. 19, 2014 - Marketwired
Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Safe and Increases CD4 Counts in People Living With HIV 3:35 p.m. Nov. 19, 2014 - Marketwired
Oral OTEZLA® (Apremilast) Showed Sustained Clinical Response over Two Years in Patients with Active Psoriatic Arthritis 7:30 a.m. Nov. 18, 2014 - BusinessWire - BZX
Moffitt Cancer Center Announces Development of Experimental Treatment for Myelodysplastic Syndromes, Autoimmune Diseases 9:03 a.m. Nov. 17, 2014 - BusinessWire - BZX

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Omega Point's MCP Secures Anthropic Verification

Updated Category News Views 25

In a world where investment decisions ride on razor-thin margins, Omega Point's MCP gains top-tier verification. Anthropic's seal of approval is stamped firmly on it, signalling to the wise investors out there that this engine ain't smoking mirrors. Since May, this player has been doing the rounds, but now, with Anthropic’s verification, it’s like Omega Point just...

Continue Reading
Wagner Logistics Gears Up for Major Expansion in Liberty

Updated Category News Views 34

Imagine waking up to news like this: Wagner Logistics is laying down some serious roots in Liberty, MO. They’ve snagged a deal with a local manufacturer that’s got them renting out over 830,000 square feet of warehouse space. Seems Wagner's got a knack for living large. More Than Just a Warehouse Gig Wagner's not just popping up another dusty shelf space; they're...

Continue Reading
JiMMYBAR! Unveils World's First Creatine Trail Mix

Updated Category News Views 24

The New Face of Snacking: Creatine Trail Mix I'll tell you right off the bat, JiMMYBAR! seems to be cornering the snack world with an odd—but interesting—twist. They've just launched the world's first Creatine + Protein Trail Mix, blending muscle-building nutrients with the classic crunch of trail mix. Sounds quirky, and it’s exclusive to their site, JiMMYBARs.com....

Continue Reading
WIN Expands Leadership Amidst Rapid Growth Surge

Updated Category News Views 30

Why WIN's Leadership Shake-Up Matters Change is afoot at the fertility and family support powerhouse WIN, and there's no mistaking the bold handwriting on the wall. As they swell towards supporting one million families, WIN's revamping their leadership table with three key players aimed at pushing the envelope further than before. They've got Claudio Stefan, Stacey...

Continue Reading
AI-Powered Travel Transformation in Norway Revealed

Updated Category News Views 23

AI-Driven Travel Meets Norway's Authentic Charm Well, folks, once again we're staring down the barrel of technology going full throttle in the travel game. Mindtrip, the savvy AI-powered travel platform, just inked a deal with the Norwegian Travel Cluster. It's their first tango in Europe, and they're not dipping their toes—they're diving headfirst into the icy fjords....

Continue Reading
Tessa AI: Revolutionizing Biomedical Research with AI

Updated Category News Views 23

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...

Continue Reading
Jaguar Promise Tackles College Cost for Texas Students

Updated Category News Views 25

Transforming Aspirations into Achievements In the heart of San Antonio, something’s cooking at A&M University-San Antonio, and it's not just the classic breakfast tacos. They've hit a record-breaking enrollment of 7,697 students this Fall, with 1,322 being fresh-faced first-timers. And while that might grab your attention, the real headliner is their Jaguar Promise...

Continue Reading
A1 Refrigeration Keeps East Texas Homes Comfortable Year-Round

Updated Category News Views 32

Homeowners in East Texas would agree: the last thing you want is your HVAC system throwing a tantrum when you're in the thick of a scorching summer or a biting winter. That's where A1 Refrigeration & Air Conditioning steps in, making sure folks in Jasper, Brookeland, and Kirbyville aren't left sweating bullets or shivering in their boots. Preventive Maintenance: A...

Continue Reading
Marshall Goldman Expands Footprint with Marino Acquisition

Updated Category News Views 40

Revving Up in Florida: Marshall Goldman's Strategic Leap If you're tuned into the luxury car scene, you probably already heard Marshall Goldman is making moves into Florida. Buying Marino Performance Motors of West Palm Beach isn't just another notch on their belt—it's a strategic leap into their second-largest market. This ain't merely about showroom floor space. Think...

Continue Reading
FCS Drives Key FDA Approvals in Cancer Treatment

Updated Category News Views 28

Florida Cancer Specialists: Changing the Cancer Treatment Game Some organizations toot their horns, but every now and then, a group truly shakes up the playing field. Take Florida Cancer Specialists & Research Institute (FCS), for instance. Over years of relentless research, FCS has nailed its role in securing two significant FDA approvals aimed at expanding treatment...

Continue Reading

Top 5 Most Recently Viewed Articles

Imac Holdings Navigates Troubling Times and Financial Strains

Updated Category News Views 309

Imac Holdings Faces 52-Week Low in Turbulent Market Imac Holdings Inc (NASDAQ: IMAC) is experiencing significant challenges as its stock price has hit a 52-week low of $0.96. This decline represents a staggering 52.36% drop in its stock value over the past year. Investors are feeling the pressure as the company fights against an array of market adversities. The current...

Continue Reading
Kiniksa Pharmaceuticals' Upgraded Price Target Sparks Interest

Updated Category News Views 81

Kiniksa Pharmaceuticals Receives Price Target Upgrade Recently, Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) experienced a surge in interest following Evercore ISI's adjustment of its price target on the company’s stock. The new target is set at $35, an increase from the previous $30, and comes alongside a retained Outperform rating. This update is a positive reflection...

Continue Reading
Investigation Launched into American Woodmark Corporation Sale

Updated Category News Views 196

New Investigation Announced for American Woodmark Corporation Recently, attention has been drawn to American Woodmark Corporation (NASDAQ: AMWD) as a class action law firm starts investigating the terms of its proposed sale to MasterBrand, Inc. This investigation arises from the concern that the sale may not be beneficial for shareholders, presenting questions about...

Continue Reading
Virax Biolabs' Strategic Direction and Innovations for 2026

Updated Category News Views 202

Virax Biolabs' Commitment to Innovation and Progress Virax Biolabs' proprietary diagnostic technology targets post-acute infection syndromes (PAIS), including the challenging Long COVID. This year is critical for data emergence, especially after numerous clinical milestones achieved recently. Virax Biolabs Group Limited (NASDAQ: VRAX), a pioneering biotechnology firm, has...

Continue Reading
Aebi Schmidt Group Declares Historic Dividend Following Nasdaq Listing

Updated Category News Views 123

Aebi Schmidt Group Makes History with First Dividend Payment Aebi Schmidt Group (NASDAQ: AEBI) has taken a monumental step in its journey by declaring its first-ever dividend payout. As a leader in the specialty vehicles sector, this announcement marks a significant milestone for the company. Details of the First Dividend The company’s decision follows its successful...

Continue Reading